Patent Assignment
Reel/Frame 022276/0362
Corrective Assignment to Correct the to Correct the Assignees Address Previously Recorded on Reel 016092 Frame 0839. Assignor(S) Hereby Confirms the the Entire Right, Title and Interest in and to Said Invention and Any Renewals, Reissues, Reexamination and Extensions Thereof..
Recorded: 2009-02-18
Pages: 7
Assignors
HASLAM, ROBERT PAUL
Executed: 2004-12-06
TRESPIDI, LAURA ANNA
Executed: 2004-12-13
FERDINANDO, JOSEPHINE CHRISTINE
Executed: 2004-11-26
Assignee
SHIRE BIOCHEM INC.
2250 ALFRED-NOBEL BOULEVARD, SUITE 500, ST-LAURENT, QUEBEC, CANADA
Covered Properties
(2)
Pharmaceutical Formulation Comprising Lanthanum Compounds
Pharmaceutical Formulation Comprising Lanthanum Compounds
Application:
12/237,381 →
Publication:
US 2009/0017133
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 21, 2004
From: HASLAM, ROBERT PAUL; TRESPIDI, LAURA ANNA; FERDINANDO, JOSEPHINE CHRISTINE
To: SHIRE BIOCHEM INC.
Reel/Frame 016092/0839 →
Change of Name
Jul 8, 2009
From: SHIRE BIOCHEM INC.
To: SHIRE CANADA INC.
Reel/Frame 022928/0057 →
Assignment of Assignor's Interest
Apr 19, 2021
From: TAKEDA CANADA INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055963/0992 →